Wang Qun, Li Yaqiong, Li Jiamei, Yao Zhigang, Ma Xiaochun, Ma Ji-Wei
Department of Ophthalmology, The 4th People's Hospital of Jinan, Jinan, Shandong, China.
Department of Pathology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, PR China.
J Cancer Res Ther. 2022 Sep;18(5):1372-1379. doi: 10.4103/jcrt.jcrt_543_22.
Delta and Notch-like endothelial growth factor-related receptor (DNER) is a transmembrane protein that mediates signal communication between neurons and glial cells. This study was performed to elucidate the specific mechanism by which DNER inhibits human glioma growth. RNA sequencing was used to detect differentially expressed genes after DNER inhibition in glioma cells. The functions of the Torsin family 4 member A (TOR4A) gene were explored through cell proliferation and clonogenic assays, flow cytometric analysis, in vitro cell migration and invasion assays, in vivo glioma transplantation, and human glioma tissue analysis using the Chinese Glioma Genome Atlas database. Protein expression levels were determined using the western blot assay. We found that TOR4A was highly expressed after the inhibition of DNER in glioma cells. The prognosis of patients with gliomas that expressed high levels of TOR4A was worse than those with low levels of the protein. TOR4A promoted the proliferation of glioma cells and inhibited their apoptosis, likely by enhancing the expression of phosphorylated protein kinase B (p-AKT) and inhibiting that of antiapoptotic proteins. We confirmed that TOR4A is an oncogene and that DNER acts as a tumor suppressor gene by inhibiting TOR4A and its functions of promoting p-AKT and inhibiting antiapoptotic protein expression.
Delta与Notch样内皮生长因子相关受体(DNER)是一种跨膜蛋白,介导神经元与神经胶质细胞之间的信号传导。本研究旨在阐明DNER抑制人胶质瘤生长的具体机制。采用RNA测序检测胶质瘤细胞中DNER抑制后差异表达的基因。通过细胞增殖和克隆形成试验、流式细胞术分析、体外细胞迁移和侵袭试验、体内胶质瘤移植以及使用中国胶质瘤基因组图谱数据库进行人胶质瘤组织分析,探讨了Torsin家族4成员A(TOR4A)基因的功能。使用蛋白质印迹法测定蛋白质表达水平。我们发现,在胶质瘤细胞中抑制DNER后,TOR4A高度表达。TOR4A高表达的胶质瘤患者的预后比该蛋白低表达的患者更差。TOR4A可能通过增强磷酸化蛋白激酶B(p-AKT)的表达并抑制抗凋亡蛋白的表达来促进胶质瘤细胞的增殖并抑制其凋亡。我们证实TOR4A是一种癌基因,而DNER通过抑制TOR-4A及其促进p-AKT和抑制抗凋亡蛋白表达的功能发挥肿瘤抑制基因的作用。